Abcam Plc (LON:ABC) insider Louise Patten purchased 1,636 shares of the stock in a transaction on Thursday, September 14th. The stock was acquired at an average cost of GBX 1,079 ($14.55) per share, for a total transaction of £17,652.44 ($23,799.97).

Shares of Abcam Plc (ABC) opened at 1034.00 on Tuesday. The stock has a 50 day moving average of GBX 1,057.28 and a 200 day moving average of GBX 958.01. The company’s market cap is GBX 2.09 billion. Abcam Plc has a 12-month low of GBX 759.50 and a 12-month high of GBX 1,113.00.

TRADEMARK VIOLATION NOTICE: This piece was first published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://theolympiareport.com/2017/09/19/abcam-plc-abc-insider-louise-patten-acquires-1636-shares.html.

Several equities research analysts have issued reports on ABC shares. Panmure Gordon reissued a “sell” rating on shares of Abcam Plc in a report on Monday, September 11th. Berenberg Bank reissued a “buy” rating and issued a GBX 1,100 ($14.83) price target on shares of Abcam Plc in a report on Monday, September 11th. Numis Securities Ltd boosted their price target on shares of Abcam Plc from GBX 1,116 ($15.05) to GBX 1,200 ($16.18) and gave the company an “add” rating in a report on Tuesday, September 12th. J P Morgan Chase & Co reissued a “neutral” rating and issued a GBX 864 ($11.65) price target on shares of Abcam Plc in a report on Tuesday, September 12th. Finally, Peel Hunt reissued a “hold” rating and issued a GBX 750 ($10.11) price target on shares of Abcam Plc in a report on Monday, September 11th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of GBX 927.67 ($12.51).

Abcam Plc Company Profile

Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.

Insider Buying and Selling by Quarter for Abcam Plc (LON:ABC)

Receive News & Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.